Old Web
English
Sign In
Acemap
>
Paper
>
P18.05 Immunotherapy Beyond First-Line in NSCLC, Still An Option
P18.05 Immunotherapy Beyond First-Line in NSCLC, Still An Option
2021
A. Modrego
H. Bote
E. Jimenez-Aguilar
Santiago Ponce-Aix
Jon Zugazagoitia
J Baena
J.M. Mazarico
J. A. Núñez
L.C. Iglesias
Luis Paz-Ares
Keywords:
Medicine
Immunotherapy
Internal medicine
Oncology
first line
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]